Mood symptoms during corticosteroid therapy: A review

Harvard Review of Psychiatry

Volumn 5, Issue 5, 1998, Pages 239-246

  Brown, E Sherwood ^a   Suppes, Trisha ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METOCLOPRAMIDE; PREDNISONE; PROCHLORPERAZINE;

ASTHMA; CANCER PATIENT; CORTICOSTEROID THERAPY; DEPRESSION; EUPHORIA; HUMAN; HYPOMANIA; KIDNEY TRANSPLANTATION; MANIA; MENTAL DISEASE; MOOD; NAUSEA; NERVOUSNESS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; VOMITING;

EID: 0031913128     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229809000307     Document Type: Review

References (57)

1. Voigt KH, Bossert S, Bretschneider S, Bliestle A, Fehm HL. Disturbed cortisol secretion in man: contrasting Cushing's disease and endogenous depression. Psychiatry Res 1985;15: 341-50.
2. Hudson JI, Hudson MS, Griffing GT, Melby JC, Pope HG Jr. Phenomenology and family history of affective disorder in Cushing's disease. Am J Psychiatry 1987;144:951-3.
3. Haskett RF. Diagnostic categorization of psychiatric disturbance in Cushing's syndrome. Am J Psychiatry 1985;142: 911-6.
4. Jeffcoate WJ, Rees LH, Tomlin S, Jones AE, Edwards CRW, Besser GM. Metyrapone in long-term management of Cushing's disease. Br Med J 1977;2:215-7.
5. Arana GW, Mossman D. The dexamethasone suppression test and depression: approaches to the use of a laboratory test in psychiatry. Endocrinol Metab Clin North Am 1988;17:21-39.
6. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, et al. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand 1992;85: 270-4.
7. Gerner RH, Wilkins JN. CSF cortisol in patients with depression, mania, or anorexia nervosa and in normal subjects. Am J Psychiatry 1983;140:92-4.
8. Depue RA, Kleiman RM, Davis P, Hutchinson M, Krauss SP. The behavioral high-risk paradigm and bipolar affective disorder, VIII: Serum free cortisol in nonpatient cyclothymic subjects selected by the General Behavior Inventory. Am J Psychiatry 1985;142:175-81.
9. Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989;30:135-9.
10. Ling MHM, Perry PJ, Tsuang MT. Side effects of corticosteroid therapy: psychiatric aspects. Arch Gen Psychiatry 1981;38: 471-7.
11. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord 1983;5:319-32.
12. Hall ROW, Popkin MK, Stickney SK, Gardner ER. Presentation of the steroid psychoses. J Nerv Ment Dis 1979;167:229-36.
13. Wolkowitz OM. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 1994;19:233-55.
14. Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment: a prospective study. Psychoneuroendocrinology 1996;21:25-31.
15. Cordess G, Folstein M, Drachman D. Psychiatric effects of alternate day steroid therapy. Br J Psychiatry 1981;138:504-6.
16. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1992;20:13-21.
17. Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 1988;27:720-5.
18. Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Psychiatry 1986;25:120-4.
19. Swinburn CR, Wakefield JM, Newman SP, Jones PW. Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease. Br J Clin Pharmacol 1988;26:709-13.
20. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, et al. Prednisone effects on neurochemistry and behavior: preliminary findings. Arch Gen Psychiatry 1990;47: 963-8.
21. Gift AG, Wood RM, Cahill CA. Depression, somatization and steroid use in chronic obstructive pulmonary disease. Int J Nurs Stud 1989;26:281-6.
22. Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease: a retrospective survey of patients in the Brompton Hospital. Thorax 1968;23: 571-81.
23. Chan L, French ME, Oliver DO, Morris PJ. High- and low-dose prednisolone. Transplant Proc 1981;13:336-8.
24. Aapro MS, Plezia PM, Alberts DS, Graham V, Jones SE, Surwit EA, et al. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol 1984;2:466-71.
25. Markman M, Sheidler V, Ettinger DS, Quaskey SA, Mellits ED. Antiemetic efficacy of dexamethasone: randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 1984;311:549-52.
26. Grunberg SM, Akerley WL, Krailo MD, Johnson KB, Baker CR, Cariffe PA. Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis. Cancer Invest 1986;4:379-85.
27. Janicak PG, Davis JM, Preskorn SH, Ayd FJ Jr. Principles and practice of psychopharmacotherapy. Baltimore: Williams & Wilkins, 1993.
28. Freymann JG, Vander JB, Marler EA, Meyer DG. Prolonged corticosteroid therapy of chronic lymphocytic leukaemia and the closely allied malignant lymphomas. Br J Haematol 1960; 6:303-23.
29. Moloney WC, Davis S, Hieber RD. The use of steroid hormones in the management of hematologic disorders. GP 1961;24: 101-6.
30. Kofman S, Perlia CP, Boesen E, Eisenstein R, Taylor SG III. The role of corticosteroids in the treatment of malignant lymphomas. Cancer 1962;15:338-45.
31. Harter JG, Reddy WJ, Thorn GW. Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 1963;269:591-6.
32. Nielsen JB, Drivsholm A, Fischer F, Brøchner-Mortensen K. Long-term treatment with corticosteroids in rheumatoid arthritis. Acta Med Scand 1963;173:177-83.
33. Treadwell BLJ, Sever ED, Savage O, Copeman WSC. Side-effects of long-term treatment with corticosteroids and corticotrophin. Lancet 1964;1:1121-3.
34. Hall TC, Choi OS, Abadi A, Krant MJ. High-dose corticosteroid therapy in Hodgkin's disease and other lymphomas. Ann Intern Med 1967;66:1144-53.
35. Hayreh SS, Watson PG. Prednisolone-21-stearoylglycolate in scleritis. Br J Ophthalmol 1970;54:394-8.
36. The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972;13:694-8.
37. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol 1976;112:962-70.
38. Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992;128:1467-73.
39. Blazer DG II, Petrie WM, Wilson WP. Affective psychoses following renal transplant. Dis Nerv Syst 1976;37:663-7.
40. McCabe MS, Corry RJ. Psychiatric illness and human renal transplantation. J Clin Psychiatry 1978;39:393-5, 398-400.
41. Sharfstein SS, Sack DS, Fauci AS. Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. JAMA 1982;248:2987-9.
42. Reckart MD, Eisendrath SJ. Exogenous corticosteroid effects on mood and cognition: case presentations. Int J Psychosom 1990;37:57-61.
43. Bräunig P, Bleistein J, Rao ML. Suicidality and corticosteroid-induced psychosis [Letter]. Biol Psychiatry 1989;26:209-10.
44. Goodwin FK, Bunney WE Jr. Depressions following reserpine: a reevaluation. Semin Psychiatry 1971;3:435-48.
45. Post RM. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990;23:3-17.
46. Clark LD, Quarton GC, Cobb S, Bauer W. Further observations on mental disturbances associated with cortisone and ACTH therapy. N Engl J Med 1953;249:178-83.
47. Krauthammer C, Merman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 1978;35:1333-9.
48. Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAMA 1979;241:1011-2.
49. Reus VI, Dark K, Van Peeke H, Johnson R, Wolkowitz OM. Lithium prophylaxis of steroid-induced changes in behavior and neurochemistry [Abstract]. Biol Psychiatry 1991;29(9 suppl):162A.
50. Kemp K, Lion JR, Magram G. Lithium in the treatment of a manic patient with multiple sclerosis: a case report. Dis Nerv Syst 1977;38:210-1.
51. Silva RG, Tolstunov L. Steroid-induced psychosis: report of case. J Oral Maxillofac Surg 1995;53:183-6.
52. Grigg JR. Prednisone mood disorder with associated catatonia. J Geriatr Psychiatry Neurol 1989;2:41-4.
53. Baloch N. 'Steroid psychosis': a case report. Br J Psychiatry 1974;124:545-6.
54. Hall RCW, Popkin MK, Kirkpatrick B. Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis 1978;166:738-42.
55. Pariante CM, Pearce BD, Pisell TL, Miller AH. Desmethylimipramine induces glucocorticoid receptor translocation in vitro [Abstract]. New Research Program and Abstracts of the 149th annual meeting of the American Psychiatric Association, New York, May 1996.
56. Pepin MC, Pothier F, Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1992;42:991-5.
57. Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatrie complications. Cancer Invest 1989;7:47991.